Chapter 1: The impact of the reduction in tobacco smoking on U.S. lung cancer mortality, 1975-2000: An introduction to the problem

Risk Analysis

Volumn 32, Issue SUPPL.1, 2012, Pages

  Feuer, Eric J ^a   Levy, David T ^b   Mccarthy, William J ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

Population modeling; Smoking

Indexed keywords

CIGARETTE SMOKING; DEATH RATES; LOWER BOUNDS; LUNG CANCER; LUNG CANCER MORTALITY; MODEL ASSUMPTIONS; MODELING NETWORKS; MULTIPLE MODELS; NATIONAL CANCER INSTITUTE; NATIONAL HEALTH INTERVIEW SURVEY; POPULATION MODELING; SMOKING; TOBACCO CONTROL; TOBACCO SMOKING; UPPER BOUND;

BIOLOGICAL ORGANS; DISEASES; POPULATION STATISTICS;

TOBACCO;

CANCER; COHORT ANALYSIS; HEALTH CARE; HEALTH POLICY; HEALTH RISK; MORTALITY; NUMERICAL MODEL; POPULATION MODELING; RISK ASSESSMENT; SMOKING; SPATIOTEMPORAL ANALYSIS;

ADULT; AGED; ARTICLE; FEMALE; HEALTH PROMOTION; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH PROMOTION; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK ASSESSMENT; SMOKING; SMOKING CESSATION; UNITED STATES;

UNITED STATES;

NICOTIANA TABACUM;

EID: 84864911789     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2011.01745.x     Document Type: Article

References (66)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al Cancer statistics, 2008. CA: A Cancer Journal for Clinicians, 2008; 58(2):71-96.
2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E et al Cancer statistics, 2004. CA: A Cancer Journal for Clinicians, 2004; 54(1):8-29.
3. Wingo PA, Ries LAG, Giovino GA, Miller DS, Rosenberg HM, Shopland DR et al Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. Journal of the National Cancer Institute, 1999; 91(8):675-690.
4. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 2012; 62;10-29.
5. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012.
6. U.S. Preventive Services Task Force. Screening for Breast Cancer: Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality, 2009.
7. U.S. Preventive Services Task Force. Screening for Colorectal Cancer: Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality, 2008.
8. U.S. Preventive Services Task Force. Screening for Skin Cancer: Recommendation Statement. Rockville, MD: Agency for Healthcare Research and Quality, 2009.
9. Bach PB, Niewoehner DE, Black WC. Screening for lung cancer-The guidelines. Chest, 2003; 123(1):83S-88S.
10. Jemal A, Thun MJ, Ries LAG, Howe HL, Weir HK, Center MM et al Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. Journal of the National Cancer Institute, 2008; 100(23):1672-1694.
11. Wynder EL, Hoffmann D. Smoking and lung cancer-Scientific challenges and opportunities. Cancer Research, 1994; 54(20):5284-5295.
12. Kluger R. Ashes to Ashes. New York: Alfred Knopf, 1996.
13. Pierce JP, Gilpin EA. A historical analysis of tobacco marketing and the uptake of smoking by youth in the United States-1890-1977. Health Psychology, 1995; 14(6):500-508.
14. Slade J. The tobacco epidemic-Lessons from history. Journal of Psychoactive Drugs, 1989; 21(3):281-291.
15. Ernster V. Mixed messages for women, a social history of cigarette smoking and advertising. New York State Journal of Medicine, 1985; 85(7):335-340.
16. Brandt AM. Recruiting women smokers: The engineering of consent. Journal of the American Medical Women's Association 1996; 51(1-2):63-66.
17. Giovino GA. The tobacco epidemic in the United States. American Journal of Preventive Medicine, 2007; 33(6):S318-S326.
18. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma-A study of 684 proved cases. JAMA: The Journal of American Medical Association, 1950; 143(4):329-336.
19. Doll R, Hill AB. Smoking and carcinoma of the lung-Preliminary report. British Medical Journal, 1950; 2(4682): 739-748.
20. Doll R, Hill AB. A study of the aetiology of carcinoma of the lung. British Medical Journal, 1952; 2(4797):1271-1286.
21. Thun MJ. When truth is unwelcome: The first reports on smoking and lung cancer. Bulletin of the World Health Organization, 2005; 83:144-145.
22. Hammond EC. Smoking in relation to lung cancer. Connecticut State Medical Journal, 1954; 18:3-9.
23. Doll R, Hill AB. Mortality in relation to smoking-Ten years' observations of British doctors. British Medical Journal, 1964; 248(i):1399-1410.
24. U.S. Department of Health Education and Welfare. Smoking and health. Pp. 386 in Surgeon General's Advisory Committee on Smoking and Health aUSPHSOotSG (ed). United States: Public Health Service. Office of the Surgeon General, 1964.
25. U.S. Department of Health and Human Services. The Health Consequences of Smoking. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
26. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. British Medical Journal, 2004; 328(7455):1519-1528.
27. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking-40 years observations on male British doctors. British Medical Journal, 1994; 309(6959):901-911.
28. Knoke JD, Burns DM, Thun MJ. The change in excess risk of lung cancer attributable to smoking following smoking cessation: An examination of different analytic approaches using CPS-I data. Cancer Causes & Control, 2008; 19(2):207-219.
29. Knoke JD, Shanks TG, Vaughn JW, Thun MJ, Burns DM. Lung cancer mortality is related to age in addition to duration and intensity of cigarette smoking: An analysis of CPS-I data. Cancer Epidemiology, Biomarkers & Prevention, 2004; 13(6):949-957.
30. Flanders WD, Lally CA, Zhu BP, Henley SJ, Thun MJ. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: Results from Cancer Prevention Study II. Cancer Research, 2003; 63(19):6556-6562.
31. Hazelton WD, Clements MS, Moolgavkar SH. Multistage carcinogenesis and lung cancer mortality in three cohorts. Cancer Epidemiology, Biomarkers & Prevention, 2005; 14(5):1171-1181.
32. Meza R, Hazelton WD, Colditz GA, Moolgavkar SH. Analysis of lung cancer incidence in the nurses' health and the health professionals' follow-up studies using a multistage carcinogenesis model. Cancer Causes & Control, 2008; 19(3):317-328.
33. Garfinkel L. Selection, follow-up, and analysis in the American Cancer Society prospective studies. National Cancer Institute Monograph, 1985; 67:49-52.
34. Stellman SD, Garfinkel L. Smoking-habits and tar levels in a new American-Cancer-Society Prospective-Study of 1.2 million men and women. Journal of the National Cancer Institute, 1986; 76(6):1057-1063.
35. Thun MJ, Heath CW. Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Preventive Medicine, 1997; 26(4):422-426.
36. Thun M, Day-Lally C, Myers DG, Calle EE, Flanders D, Zhu BP et al Trends in tobacco smoking and mortality from cigarette use in Cancer Prevention Study I (1959-1965) and II (1982-1988), pp. 305-382. Tobacco Control Monograph #8, National Cancer Institute, 1997.
37. Meara ER, Richards S, Cutiew DM. The gap gets bigger: Changes on mortality and life expectancy, by education, 1981-2000. Health Affairs, 2008; 27(2):350-360.
38. Zajacova A. Education, gender, and mortality: Does schooling have the same effect on mortality for men and women in the US? Social Science & Medicine, 2006; 63(8):2176-2190.
39. U.S. Department of Health Education and Welfare (USDHEW). Smoking and Health-A Report of the Surgeon General. Washington DC: U.S. Department of Health Education, and Welfare, Public Health Service, 1979.
40. Centers for Disease Control (CDC). Cigarette smoking among adults and trends in smoking cessation-United States, 2008. Morbidity Mortality Weekly Report, 2009; 58(44):1227-1232.
41. U.S. Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2000.
42. Levy DT, Nikolayev L, Mumford E. Recent trends in smoking and the role of public policies: Results from the SimSmoke tobacco control policy simulation model. Addiction, 2005; 100(10):1526-1536.
43. Levy DT, Chaloupka F, Gitchell J. The effects of tobacco control policies on smoking rates: A tobacco control scorecard. Journal of Public Health Management and Practice, 2004; 10(4):338-353.
44. Levy DT, Ross H, Powell L, Bauer JE, Lee HR. The role of public policies in reducing smoking prevalence and deaths caused by smoking in Arizona: Results from the Arizona tobacco policy simulation model. Journal of Public Health Management and Practice, 2007; 13(1):59-67.
45. Fichtenberg CM, Glantz SA. Association of the California tobacco control program with declines in cigarette consumption and mortality from heart disease. New England Journal of Medicine, 2000; 343(24):1772-1777.
46. Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: Systematic review. British Medical Journal, 2002; 325(7357):188-191.
47. Thun MJ, Jemal A. How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tobacco Control, 2006; 15(5):345-347.
48. Cowling DW, Kwong SL, Schlag R, Lloyd JC, Bal DG. Declines in lung cancer rates-California, 1988-1997. Morbidity Mortality Weekly Report, 2000; 49:1066-1069.
49. Moolgavkar SH, Knudson AG. Mutation and cancer-A model for human carcinogenesis. Journal of the National Cancer Institute, 1981; 66(6):1037-1052.
50. Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G et al Effects of mammography screening under different screening schedules: Model estimates of potential benefits and harms. Annals of Internal Medicine, 2009; 151(10):738-W247.
51. Levy DT, Bales S, Lam NT, Nikolayev L. The role of public policies in reducing smoking and deaths caused by smoking in Vietnam: Results from the Vietnam tobacco policy simulation model. Social Science & Medicine, 2006; 62(7): 1819-1830.
52. McMahon PM, Kong CY, Weinstein MC, Tramontano AC, Cipriano LE, Johnson BE et al Adopting helical CT screening for lung cancer potential health consequences during a 15-year period. Cancer, 2008; 113(12):3440-3449.
53. Anderson CM, Burns DM, Dodd KW, Feuer EJ. Birth cohort specific estimates of smoking behaviors for the U.S. population. Risk Analysis, 2012; 32(S1):S14-S24.
54. Rosenberg MA, Feuer EJ, Yu B, Sun J, Henley SJ, Shanks TG, Anderson CM, McMahon PM, Thun MJ, Burns DM. Cohort life tables by smoking status, removing lung cancer as a cause of death. Risk Analysis, 2012; 32(S1):S25-S38.
55. Holford TR, Clarke LD. Development of the counterfactual smoking histories used to assess the effects of tobacco control. Risk Analysis, 2012; 32(S1):S39-S50.
56. Jeon J, Meza R, Krapcho M, Clarke LD, Byrne J, Levy DT. Actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation. Risk Analysis, 2012; 32(S1):S51-S68.
57. McCarthy WJ, Meza R, Jeon J, Moolgavkar SH. Lung cancer in never smokers: Epidemiology and risk prediction models. Risk Analysis, 2012; 32(S1):S69-S84.
58. Schultz FW, Boer R, de Koning HJ. Description of MISCAN-Lung, the Erasmus MC lung cancer microsimulation model for evaluating cancer control interventions. Risk Analysis, 2012; 32(S1):S85-S98.
59. Hazelton WD, Jeon J, Meza R, Moolgavkar SH. The FHCRC lung cancer model. Risk Analysis, 2012; 32(S1):S99-S116.
60. McMahon PM, Kong CY, Johnson BE, Weinstein MC, Weeks JC, Tramontano AC, Cipriano LE, Bouzan C, Gazelle GS. The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Analysis, 2012; 32(S1):S117-S124.
61. Levy DT, Blackman K, Zaloshnja E. A macro-model of smoking and lung cancer: Examining aggregate trends in lung cancer rates unsing the CPS-I and CPS-II and two-stage clonal expansion models. Risk Analysis, 2012; 32(S1):S125-S141.
62. Foy M, Deng L, Spitz M, Gorlova O, Kimmel M. Rice-MD Anderson lung cancer model. Risk Analysis, 2012; 32(S1):S142-S150.
63. Holford TR, Ebisu K, McKay L, Oh C, Zheng T. Yale lung cancer model. Risk Analysis, 2012; 32(S1):S151-S165.
64. McMahon PM, Hazelton WD, Kimmel M, Clarke LD. CISNET lung models: Comparison of model assumptions and model structures. Risk Analysis, 2012; 32(S1):S166-S178.
65. Holford TR, Levy DT. Comparing the adequacy of carcinogenesis models in estimating U.S. population rates for lung cancer mortality. Risk Analysis, 2012; 32(S1):S179-S189.
66. Boer R, Moolgavkar SH, Levy DT. Impact of tobacco control on lung cancer mortality in the United States over the period 1975-2000-Summary and limitations. Risk Analysis, 2012; 32(S1):S190-S202.